April 15, 2012 — On Thursday, April 19, through an exclusive webinar sponsored by Integrative Therapeutics, registered pharmacist, Alan Simon, will discuss how common birth control and hormone therapy prescriptions have been shown to affect nutrient status.
During this webinar, Simon will review extensive evidence of known interactions from the peer-reviewed medical literature, and present nutritional interventions and precautions for optimal patient care.
According to IMS National Sales Perspectives from IMS Health, the number of prescriptions dispensed has declined each year from 2006 through 2010 for each of the four types of commercial HT products tracked: estrogens, progestogens, estrogen-progestogen combinations, and androgen-estrogen combinations. However, in 2010, collective U.S. sales of these products at even at wholesale prices were still at astoundingly high levels:
- Estrogens: $1.576 billion, up from $1.542 billion in 2009
- Progestogens: $243 million, up from $229 million in 2009
- Estrogen-progestogen combinations: $399 million, up from $394 million in 2009
“So many women take a form of hormone therapy, either as an effective form of contraception, or for treatment of health issues and a high percentage of these women are not aware of the adverse side effects this may cause,” Simon stated. “This webinar is meant to inform practitioners of the various adverse effects that certain birth control and other hormone replacement therapies may have so they can better inform and care for their patients.”
To register, or for more information on all Integrative Therapeutics sponsored educational events, go to integrativeinc.com/Education/Events.aspx.
Source: Integrative Therapeutics, integrativeinc.com
